Zalicus Inc.
Overview
Zalicus Inc. is a biopharmaceutical company focused on the discovery and development of novel therapeutics using its proprietary combination high-throughput screening platform. The company aims to deliver innovative pain and inflammation treatments.
Therapeutic areas
PainInflammation
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Zalicus Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Related companies
American Cyanamid Company (as Wyeth-Ayerst Laboratories)
United States
Amgen Inc.
United States
Biora Therapeutics, Inc.
United States
Cytonics Corporation
United States
Gossamer Bio, Inc.
United States
Incyte Corporation
United States
Kiniksa Pharmaceuticals, Ltd.
United States
Millennium Pharmaceuticals, Inc.
United States
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.